The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo
Open accessAbstract
We have previously reported that hepatitis B virus (HBV)–specific CD8+ cytotoxic T lymphocytes and CD4+ helper T lymphocytes can inhibit HBV replication in the liver of HBV transgenic mice by secreting interferon (IFN)-γ when they recognize viral antigen. To determine whether an activated innate immune system can also inhibit HBV replication, in this study we activated natural killer T (NKT) cells in the liver of HBV transgenic mice by a single injection of α-galactosylceramide (α-GalCer), a glycolipid antigen presented to Vα14+NK1.1+ T cells by the nonclassical major histocompatibility complex class I–like molecule CD1d. Within 24 h of α-GalCer injection, IFN-γ and IFN-α/β were detected in the liver of HBV transgenic mice and HBV replication was abolished. Both of these events were temporally associated with the rapid disappearance of NKT cells from the liver, presumably reflecting activation-induced cell death, and by the recruitment of activated NK cells into the organ. In addition, prior antibody-mediated depletion of CD4+ and CD8+ T cells from the mice did not diminish the ability of α-GalCer to trigger the disappearance of HBV from the liver, indicating that conventional T cells were not downstream mediators of this effect. Finally, the antiviral effect of α-GalCer was inhibited in mice that are genetically deficient for either IFN-γ or the IFN-α/β receptor, indicating that most of the antiviral activity of α-GalCer is mediated by these cytokines. Based on these results, we conclude that α-GalCer inhibits HBV replication by directly activating NKT cells and by secondarily activating NK cells to secrete antiviral cytokines in the liver. In view of these findings, we suggest that, if activated, the innate immune response, like the adaptive immune response, has the potential to control viral replication during natural HBV infection. In addition, the data suggest that therapeutic activation of NKT cells may represent a new strategy for the treatment of chronic HBV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Self-citationNATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Hepatitis B Virus Immunopathogenesis
Chisari, F. V. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.29 · Cited by 1,609
Self-citationIdentification of a monoclonal antibody specific for a murine T3 polypeptide.
Leo, O., Foo, M., Sachs, D. H., Samelson, L. E., & Bluestone, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1374 · Cited by 1,593
MacMicking, J. D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q.-W., Sokol, K., Hutchinson, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90085-3 · Cited by 1,444
MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and Function
Bendelac, A., Rivera, M. N., Park, S.-H., & Roark, J. H. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.535 · Cited by 1,326
Dialynas, D. P., Quan, Z. S., Wall, K. A., Pierres, A., Quintáns, J., Loken, M. R., Pierres, M., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2445 · Cited by 1,273
Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., & Taniguchi, M. (1997) · Science · doi:10.1126/science.278.5343.1623 · Cited by 1,237
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Self-citationTHE MOLECULAR BIOLOGY OF THE HEPATITIS B VIRUSES
Ganem, D., & Varmus, H. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003251 · Cited by 1,084
Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R., & Chisari, F. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80295-2 · Cited by 1,083
Self-citationLantz, O., & Bendelac, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1097 · Cited by 1,057
Recognition of a lipid antigen by CD1-restricted αβ+ T cells
Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T., & Brenner, M. B. (1994) · Nature · doi:10.1038/372691a0 · Cited by 978
Carnaud, C., Lee, D., Donnars, O., Park, S.-H., Beavis, A., Koezuka, Y., & Bendelac, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4647 · Cited by 854
Self-citationCD1-Restricted T Cell Recognition of Microbial Lipoglycan Antigens
Sieling, P. A., Chatterjee, D., Porcelli, S. A., Prigozy, T. I., Mazzaccaro, R. J., Soriano, T., Bloom, B. R., Brenner, M. B., Kronenberg, M., Brennan, P. J., et al. (1995) · Science · doi:10.1126/science.7542404 · Cited by 740
High-level hepatitis B virus replication in transgenic mice
Guidotti, L. G., Matzke, B., Schaller, H., & Chisari, F. V. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6158-6169.1995 · Cited by 642
Self-citationCrystal Structure of Mouse CD1: An MHC-Like Fold with a Large Hydrophobic Binding Groove
Zeng, Z.-H., Castaño, A. R., Segelke, B. W., Stura, E. A., Peterson, P. A., & Wilson, I. A. (1997) · Science · doi:10.1126/science.277.5324.339 · Cited by 630
Vremec, D., Zorbas, M., Scollay, R., Saunders, D. J., Ardavin, C. F., Wu, L., & Shortman, K. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.47 · Cited by 625
Macrophages and Inflammatory Mediators in Tissue Injury
Laskin, D. L., & Pendino, K. J. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003255 · Cited by 617
Ledbetter, J. A., Rouse, R. V., Micklem, H. S., & Herzenberg, L. A. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.2.280 · Cited by 613
Murine CD1d-Restricted T Cell Recognition of Cellular Lipids
Gumperz, J. E., Roy, C., Makowska, A., Lum, D., Sugita, M., Podrebarac, T., Koezuka, Y., Porcelli, S. A., Cardell, S., Brenner, M. B., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80174-0 · Cited by 469
Self-citationNatori, T., Morita, M., Akimoto, K., & Koezuka, Y. (1994) · Tetrahedron · doi:10.1016/s0040-4020(01)86991-x · Cited by 397
Self-citationBurdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · PubMed · Cited by 381
Self-citationSingh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y., & Kaer, L. V. (1999) · PubMed · Cited by 358
Self-citationDoherty, D. G., Norris, S., Madrigal-Estebas, L., McEntee, G., Traynor, O., Hegarty, J. E., & O’Farrelly, C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2314 · Cited by 350
NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function.
MacDonald, H. R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.633 · Cited by 345
Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
Cobbold, S. P., Martin, G., Qin, S., & Waldmann, H. (1986) · Nature · doi:10.1038/323164a0 · Cited by 335
Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3271 · Cited by 334
Self-citationSelective induction of NK cell proliferation and cytotoxicity by activated NKT cells
Eberl, G., & MacDonald, H. R. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<985::aid-immu985>3.0.co;2-e · Cited by 326
Tissue-Specific Segregation of CD1d-Dependent and CD1d-Independent NK T Cells
Eberl, G., Lees, R., Smiley, S. T., Taniguchi, M., Grusby, M. J., & MacDonald, H. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6410 · Cited by 324
Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y., & Van Kaer, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2373 · Cited by 311
Self-citationOhteki, T., & MacDonald, H. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.699 · Cited by 300
McClary, H., Koch, R., Chisari, F. V., & Guidotti, L. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2255-2264.2000 · Cited by 255
Self-citationAgelasphins, novel α-galactosylceramides from the marine sponge Agelas mauritianus
Natori, T., Koezuka, Y., & Higa, T. (1993) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)73889-5 · Cited by 253
Self-citationRapid Death and Regeneration of NKT Cells in Anti-CD3ε- or IL-12-Treated Mice
Eberl, G., & MacDonald, H. R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80617-2 · Cited by 225
Mouse CD1 is mainly expressed on hemopoietic-derived cells
Brossay, L., Jullien, D., Cardell, S., Sydora, B. C., Burdin, N., Modlin, R. L., & Kronenberg, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1216 · Cited by 220
Guidotti, L. G., Borrow, P., Hobbs, M. V., Matzke, B., Gresser, I., Oldstone, M. B., & Chisari, F. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4589 · Cited by 201
Self-citationNorris, S., Doherty, D. G., Collins, C., McEntee, G., Traynor, O., Hegarty, J. E., & O’Farrelly, C. (1999) · Human Immunology · doi:10.1016/s0198-8859(98)00098-6 · Cited by 199
Apostolou, I., Takahama, Y., Belmant, C., Kawano, T., Huerre, M., Marchal, G., Cui, J., Taniguchi, M., Nakauchi, H., Fournié, J.-J., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5141 · Cited by 196
Denkers, E., Scharton‐Kersten, T., Barbieri, S., Caspar, P., & Sher, A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.1.131 · Cited by 148
Cavanaugh, V. J., Guidotti, L. G., & Chisari, F. V. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2630-2637.1998 · Cited by 145
Self-citationStructural requirements for galactosylceramide recognition by CD1-restricted NK T cells.
Brossay, L., Naidenko, O. V., Burdin, N., Matsuda, J. L., Sakai, T., & Kronenberg, M. (1998) · PubMed · Cited by 141
Brossay, L., Naidenko, O. V., Burdin, N., Matsuda, J. L., Sakai, T., & Kronenberg, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5124 · Cited by 131
Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice
Guidotti, L. G., McClary, H., Loudis, J. M., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1247 · Cited by 120
Self-citationLipid antigen presentation in the immune system; lessons learned from CD 1 d knockout mice
Hong, S., Scherer, D. C., Singh, N., Mendiratta, S. K., Serizawa, I., Koezuka, Y., & Kaer, L. V. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01304.x · Cited by 119
Self-citation
Cited by
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
CD1: Antigen Presentation and T Cell Function
Brigl, M., & Brenner, M. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104608 · Cited by 1,035
Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
Guidotti, L. G., & Chisari, F. V. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.65 · Cited by 996
Self-citationThimme, R., Wieland, S., Steiger, C., Ghrayeb, J., Reimann, K. A., Purcell, R. H., & Chisari, F. V. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.68-76.2003 · Cited by 979
Self-citation
Metadata
- Authors
- Kakimi, K., Guidotti, L. G., Koezuka, Y., & Chisari, F. V.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2000-09-25
- Volume
- 192
- Issue
- 7
- Pages
- 921-930
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2124491055
- Cited by
- 584
- References
- 49
- FWCI
- 24.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.